US5270323A
(en)
*
|
1990-05-31 |
1993-12-14 |
Pfizer Inc. |
Method of treating impotence
|
EP1262182A3
(en)
*
|
1991-11-26 |
2003-02-26 |
Sepracor Inc. |
Methods and compositions for treating hypertension, angina and other disorders using optically pure(-) amlodipine
|
US6057344A
(en)
|
1991-11-26 |
2000-05-02 |
Sepracor, Inc. |
Methods for treating hypertension, and angina using optically pure (-) amlodipine
|
US6162802A
(en)
*
|
1992-03-10 |
2000-12-19 |
Papa; Joseph |
Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
|
AT399718B
(de)
*
|
1992-04-16 |
1995-07-25 |
Lek Tovarna Farmacevtskih |
Inklusionskomplexe von optisch aktiven und racemischen 1,4-dihydropyridinen mit methyl-beta- cyclodextrin oder anderen cyclodextrinderivaten, ein verfahren zur herstellung von optisch aktiven dihydropyridinen und deren inklusionskomplexen und diese komplexe enthaltende pharmazeutische formulierungen
|
SI9200344B
(sl)
*
|
1992-11-26 |
1998-06-30 |
Lek, |
Postopek za pripravo amlodipin benzensulfonata
|
US5389654A
(en)
*
|
1992-11-26 |
1995-02-14 |
Lek, Tovarna, Farmacevtskih In Kemicnih . . . |
3-ethyl 5-methyl(±)2-[2-(N-tritylamino)ethoxymethyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-6-methyl-3,5-pyridinedicarboxylate
|
USRE39384E1
(en)
|
1993-09-01 |
2006-11-07 |
Smithkline Beecham P.L.C. |
Substituted thiazolidinedione derivatives
|
US6221335B1
(en)
*
|
1994-03-25 |
2001-04-24 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
ES2193233T3
(es)
|
1995-03-16 |
2003-11-01 |
Pfizer |
Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
|
HU221810B1
(hu)
*
|
1997-08-12 |
2003-01-28 |
EGIS Gyógyszergyár Rt. |
Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
WO1999018957A1
(en)
*
|
1998-03-26 |
1999-04-22 |
Reddy-Cheminor, Inc. |
Stable pharmaceutical composition containing amlodipine besylate and atenolol
|
PL189666B1
(pl)
*
|
1998-04-09 |
2005-09-30 |
Adamed Sp Z Oo |
Sposób otrzymywania benzenosulfonianu amlodypiny
|
NZ509260A
(en)
|
1998-07-10 |
2003-09-26 |
Novartis Ag |
Pharmaceutical composition containing valsartan and a calcium channel blocker
|
US7303768B2
(en)
*
|
1998-07-24 |
2007-12-04 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
US20050158408A1
(en)
*
|
1998-07-24 |
2005-07-21 |
Yoo Seo H. |
Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
|
US20070072828A1
(en)
*
|
1998-07-24 |
2007-03-29 |
Yoo Seo H |
Bile preparations for colorectal disorders
|
US7772220B2
(en)
*
|
2004-10-15 |
2010-08-10 |
Seo Hong Yoo |
Methods and compositions for reducing toxicity of a pharmaceutical compound
|
US7129265B2
(en)
*
|
1999-04-23 |
2006-10-31 |
Mason R Preston |
Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
|
DE60011424T2
(de)
|
1999-05-27 |
2005-08-25 |
Pfizer Products Inc., Groton |
Gegenseitige prodrugs von amlopidin und atorvastatin
|
HN2000000050A
(es)
|
1999-05-27 |
2001-02-02 |
Pfizer Prod Inc |
Sal mutua de amlodipino y atorvastatina
|
UA72768C2
(en)
*
|
1999-07-05 |
2005-04-15 |
Richter Gedeon Vegyeszet |
A method for obtaining amilodipine benzenesulphonate
|
US6521647B2
(en)
|
2000-04-04 |
2003-02-18 |
Pfizer Inc. |
Treatment of renal disorders
|
US6835742B2
(en)
|
2000-08-04 |
2004-12-28 |
R. Preston Mason |
Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release
|
GB0027410D0
(en)
*
|
2000-11-09 |
2000-12-27 |
Pfizer Ltd |
Mutual prodrug of amlodipine and atorvastatin
|
US6737430B2
(en)
|
2000-11-09 |
2004-05-18 |
Pfizer, Inc. |
Mutual prodrug of amlodipine and atorvastatin
|
CA2433191A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Pfizer Limited |
Aspartate derivative of amlodipine as calcium channel antagonist
|
CA2433190C
(en)
|
2000-12-29 |
2005-11-15 |
Pfizer Limited |
Amlodipine hemimaleate
|
CA2433288C
(en)
*
|
2000-12-29 |
2006-06-13 |
Pfizer Limited |
Process for making amlodipine maleate
|
EP1309554A1
(en)
|
2000-12-29 |
2003-05-14 |
Synthon Licensing, Ltd. |
Amide derivative of amlodipine
|
MXPA03005882A
(es)
|
2000-12-29 |
2005-04-19 |
Pfizer Ltd |
Derivado amida de amlodipina.
|
US6653481B2
(en)
*
|
2000-12-29 |
2003-11-25 |
Synthon Bv |
Process for making amlodipine
|
EP1346214A2
(en)
|
2000-12-29 |
2003-09-24 |
Pfizer Limited |
Reference standards and processes for determining the purity or stability of amlodipine maleate
|
EP1309556B1
(en)
|
2000-12-29 |
2004-11-24 |
Pfizer Limited |
Amlodipine fumarate
|
US7335380B2
(en)
|
2000-12-29 |
2008-02-26 |
Synthon Ip Inc. |
Amlodipine free base
|
AT5874U1
(de)
|
2000-12-29 |
2003-01-27 |
Bioorg Bv |
Pharmazeutische zubereitungen enthaltend amlodipinmaleat
|
EP1221438B1
(de)
*
|
2001-01-09 |
2007-03-14 |
Siegfried Generics International AG |
Salze von Amlodipin-Mesylat
|
GB0103046D0
(en)
|
2001-02-07 |
2001-03-21 |
Novartis Ag |
Organic Compounds
|
KR100452491B1
(ko)
*
|
2001-03-29 |
2004-10-12 |
한미약품 주식회사 |
신규한 결정형 암로디핀 캠실레이트 염 및 그의 제조방법
|
US20030027848A1
(en)
*
|
2001-06-15 |
2003-02-06 |
Anne Billotte |
Stabilized formulations
|
US7153970B2
(en)
|
2001-07-06 |
2006-12-26 |
Lek Pharmaceuticals D.D. |
High purity amlodipine benzenesulfonate and a process for its preparation
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
US6680334B2
(en)
|
2001-08-28 |
2004-01-20 |
Pfizer Inc |
Crystalline material
|
US7544681B2
(en)
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
US20040001886A1
(en)
*
|
2001-10-17 |
2004-01-01 |
Dr. Reddy's Laboratories Limited |
Stabilized pharmaceutical formulations containing amlodipine maleate
|
US6828339B2
(en)
*
|
2001-11-21 |
2004-12-07 |
Synthon Bv |
Amlodipine salt forms and processes for preparing them
|
HU226642B1
(en)
*
|
2001-12-17 |
2009-05-28 |
Egis Gyogyszergyar Nyilvanosan |
Amlodipine bezylate tablets having extended stability and process for producing the same
|
NL1019882C2
(nl)
*
|
2002-02-01 |
2003-08-04 |
Synthon Licensing |
Amlodipine vrije base.
|
AU2003217676B2
(en)
|
2002-02-22 |
2009-06-11 |
Takeda Pharmaceutical Company Limited |
Active agent delivery systems and methods for protecting and administering active agents
|
WO2003089414A1
(en)
*
|
2002-04-13 |
2003-10-30 |
Hanlim Pharmaceutical Co., Ltd. |
Amlodipine nicotinate and process for the preparation thereof
|
EP2258401B1
(en)
|
2002-05-06 |
2014-07-09 |
Endocyte, Inc. |
Folate-receptor targeted imaging agents
|
EG24716A
(en)
|
2002-05-17 |
2010-06-07 |
Novartis Ag |
Combination of organic compounds
|
SI21233A
(sl)
*
|
2002-05-31 |
2003-12-31 |
LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. |
Kristalni hidratni obliki amlodipin benzensulfonata visoke čistote, postopki za njuno pripravo in uporaba
|
US6699892B2
(en)
|
2002-06-04 |
2004-03-02 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salt of amlodipine and method of preparing the same
|
KR100538641B1
(ko)
*
|
2002-07-30 |
2005-12-22 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100462304B1
(ko)
*
|
2002-07-30 |
2004-12-17 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR20040011751A
(ko)
*
|
2002-07-30 |
2004-02-11 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100496436B1
(ko)
|
2002-07-30 |
2005-06-20 |
씨제이 주식회사 |
암로디핀의 유기산염
|
KR100467669B1
(ko)
*
|
2002-08-21 |
2005-01-24 |
씨제이 주식회사 |
암로디핀의 유기산염
|
EA007613B1
(ru)
|
2002-08-29 |
2006-12-29 |
Тайсо Фармасьютикал Ко., Лтд. |
Бензолсульфонатная соль (2s,4s)-1-циано-4-фтор-1-[(2-гидрокси-1,1-диметил)этиламино]ацетилпирролидина
|
US6784297B2
(en)
*
|
2002-09-04 |
2004-08-31 |
Kopran Limited |
Process for the preparation of anti-ischemic and anti-hypertensive drug amlodipine besylate
|
WO2004024690A1
(en)
*
|
2002-09-11 |
2004-03-25 |
Hanlim Pharmaceutical Co., Ltd. |
S-(-)-amlodipine nicotinate and process for the preparation thereof
|
AU2003253460A1
(en)
*
|
2002-09-19 |
2004-04-08 |
Cj Corporation |
Crystalline organic acid salt of amlodipine
|
US7166641B2
(en)
*
|
2002-10-02 |
2007-01-23 |
Yung Shin Pharmaceutical Industrial Co., Ltd. |
Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
|
EP1407773A1
(en)
*
|
2002-10-08 |
2004-04-14 |
Council of Scientific and Industrial Research |
A process for the preparation of s (-) amlodipine salts
|
US20040072879A1
(en)
*
|
2002-10-10 |
2004-04-15 |
Dr. Reddy's Laboratories Limited |
Crystalline 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-3-ethoxycarbonyl-5-methoxycarbonyl-6-methyl-1,4-dihydropyridine maleate salt (Amlodipine)
|
AU2002368531A1
(en)
*
|
2002-12-30 |
2004-07-22 |
Eos Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ticaret A.S. |
Isolation of dihydropyridine derivative and preparation salts thereof
|
BRPI0407038A
(pt)
|
2003-01-27 |
2006-01-17 |
Hanmi Pharm Ind Co Ltd |
Camsilato de amlodipina amorfo estável, processo para a preparação do mesmo e composição para administração oral deste
|
EP1604664A4
(en)
|
2003-01-31 |
2006-12-27 |
Sankyo Co |
MEDICAMENT FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND BLOOD HIGH PRESSURE
|
KR20040072363A
(ko)
*
|
2003-02-12 |
2004-08-18 |
주식회사 대웅 |
신규한 암로디핀 사이클라메이트 염 및 그의 제조방법
|
US20060270715A1
(en)
*
|
2003-02-28 |
2006-11-30 |
Singh Romi B |
Dosage forms of amlodipine and processes for their preparation
|
DE112004000712T5
(de)
*
|
2003-04-25 |
2006-10-19 |
Cipla Ltd. |
Verfahren zur Herstellung von Amlodipinmesilat-Monohydrat
|
EP2113506A3
(en)
|
2003-04-25 |
2010-02-24 |
Cadila Healthcare Limited |
Salts of clopidogrel and process for preparation
|
JP2007516227A
(ja)
*
|
2003-05-16 |
2007-06-21 |
アンビット バイオサイエンシス コーポレーション |
ピロール化合物およびその使用
|
US20050182125A1
(en)
*
|
2003-05-16 |
2005-08-18 |
Ambit Biosciences Corporation |
Pyrrole compounds and uses thereof
|
KR20060021870A
(ko)
|
2003-05-30 |
2006-03-08 |
랜박시 래보러터리스 리미티드 |
치환된 피롤 유도체와 hmg―co 억제제로서의 이의용도
|
US7145125B2
(en)
|
2003-06-23 |
2006-12-05 |
Advanced Optical Technologies, Llc |
Integrating chamber cone light using LED sources
|
US20050048118A1
(en)
*
|
2003-07-25 |
2005-03-03 |
Joan Cucala Escoi |
Modified release venlafaxine hydrochloride tablets
|
WO2005042485A1
(en)
*
|
2003-10-30 |
2005-05-12 |
Sk Chemicals, Co., Ltd. |
Acid added salts of amlodipine
|
KR100841409B1
(ko)
*
|
2003-12-16 |
2008-06-25 |
에스케이케미칼주식회사 |
암로디핀 겐티세이트 염과 이의 제조방법
|
US7262318B2
(en)
*
|
2004-03-10 |
2007-08-28 |
Pfizer, Inc. |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
US20060035940A1
(en)
*
|
2004-03-16 |
2006-02-16 |
Sepracor Inc. |
(S)-Amlodipine malate
|
PL1750862T3
(pl)
|
2004-06-04 |
2011-06-30 |
Teva Pharma |
Kompozycja farmaceutyczna zawierająca irbesartan
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
WO2006026555A2
(en)
*
|
2004-08-30 |
2006-03-09 |
Seo Hong Yoo |
Neuroprotective effect of solubilized udca in focal ischemic model
|
ATE506955T1
(de)
*
|
2004-10-15 |
2011-05-15 |
Seo Hong Yoo |
Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
|
DE602005025391D1
(de)
*
|
2004-11-01 |
2011-01-27 |
Seo Hong Yoo |
Verfahren und zusammensetzungen zur verringerung der neurodegeneration bei amyotrophischer lateralsklerose
|
ES2328384T3
(es)
*
|
2004-11-23 |
2009-11-12 |
Warner-Lambert Company Llc |
Derivados del acido 7-(2h-pirazol-3-il)-3,5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de la lipidemia.
|
WO2006059217A1
(en)
*
|
2004-12-01 |
2006-06-08 |
Ranbaxy Laboratories Limited |
Stable solid dosage forms of amlodipine besylate and processes for their preparation
|
EP1833466A1
(en)
*
|
2004-12-28 |
2007-09-19 |
Ranbaxy Laboratories Limited |
Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine
|
US20080268049A1
(en)
*
|
2005-02-11 |
2008-10-30 |
Dhaliwal Mona |
Stable Solid Dosage Forms of Amlodipine and Benazepril
|
AU2006256369B2
(en)
*
|
2005-06-07 |
2012-08-02 |
Bar-Ilan University |
Novel salts of conjugated psychotropic drugs and processes of preparing same
|
JP5148296B2
(ja)
*
|
2005-06-27 |
2013-02-20 |
第一三共株式会社 |
アンジオテンシンii受容体拮抗剤及びカルシウム拮抗剤含有医薬組成物
|
US8158146B2
(en)
|
2005-09-28 |
2012-04-17 |
Teva Pharmaceutical Industries Ltd. |
Stable combinations of amlodipine besylate and benazepril hydrochloride
|
EP1797885B1
(en)
*
|
2005-09-28 |
2008-03-26 |
Teva Pharmaceutical Industries Ltd. |
Stable combinations of amlodipine besylate and benazepril hydrochloride
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
WO2007054896A1
(en)
|
2005-11-08 |
2007-05-18 |
Ranbaxy Laboratories Limited |
Process for (3r, 5r)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
FR2894826B1
(fr)
*
|
2005-12-21 |
2010-10-22 |
Servier Lab |
Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
|
CA2659521A1
(en)
|
2006-07-17 |
2008-01-24 |
Ramot At Tel Aviv University Ltd. |
Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use in treating pain and other cns disorders
|
KR100795313B1
(ko)
|
2006-09-05 |
2008-01-21 |
현대약품 주식회사 |
암로디핀 베실레이트를 포함하는 약학 조성물
|
TWI399223B
(zh)
|
2006-09-15 |
2013-06-21 |
Daiichi Sankyo Co Ltd |
奧美沙坦酯及氨氯地平之固體劑型
|
US20080096863A1
(en)
*
|
2006-10-19 |
2008-04-24 |
Torrent Pharmaceuticals Limited |
Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor
|
CN101167724B
(zh)
*
|
2006-10-25 |
2012-08-22 |
北京华安佛医药研究中心有限公司 |
含有氨氯地平的药物组合物在制备治疗下尿路疾病药物中的用途
|
US8404896B2
(en)
|
2006-12-01 |
2013-03-26 |
Bristol-Myers Squibb Company |
N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
CA2673336A1
(en)
*
|
2006-12-21 |
2008-06-26 |
Xenoport, Inc. |
Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
|
KR100926417B1
(ko)
*
|
2007-01-29 |
2009-11-12 |
한올제약주식회사 |
N,n―디메틸 이미도디카르본이미딕 디아미드의 초산염,그의 제조방법 및 그를 포함하는 약제학적 조성물
|
WO2008124121A1
(en)
*
|
2007-04-06 |
2008-10-16 |
Scidose, Llc |
Co-therapy with and combinations of statins and 1,4-dihydropyridine-3,5-dicarboxydiesters
|
US8748648B2
(en)
|
2007-09-06 |
2014-06-10 |
Nektar Therapeutics |
Oligomer-calcium channel blocker conjugates
|
US8143314B1
(en)
*
|
2007-09-13 |
2012-03-27 |
Robert Carl Stover |
Methods and formulations for treating ineffective or decreased esophageal motility
|
CN101855204B
(zh)
*
|
2007-09-21 |
2013-09-11 |
韩兀生物制药株式会社 |
N,n-二甲基亚氨二羰酸二酰胺二羧酸盐、其制备方法及其药物组合物
|
WO2009084003A1
(en)
|
2007-12-31 |
2009-07-09 |
Lupin Limited |
Pharmaceutical compositions of amlodipine and valsartan
|
EP2252578B1
(en)
|
2008-02-11 |
2012-08-01 |
Ramot at Tel Aviv University Ltd. |
Conjugates for treating neurodegenerative diseases and disorders
|
CN101564536B
(zh)
*
|
2008-04-21 |
2010-12-15 |
鲁南制药集团股份有限公司 |
一种治疗高血压的药物组合物缓控释制剂
|
US11351168B1
(en)
|
2008-06-27 |
2022-06-07 |
Celgene Car Llc |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
US8338439B2
(en)
|
2008-06-27 |
2012-12-25 |
Celgene Avilomics Research, Inc. |
2,4-disubstituted pyrimidines useful as kinase inhibitors
|
CA2727455C
(en)
|
2008-06-27 |
2019-02-12 |
Avila Therapeutics, Inc. |
Heteroaryl compounds and uses thereof
|
US8399513B2
(en)
*
|
2008-10-20 |
2013-03-19 |
Xenoport, Inc. |
Levodopa prodrug mesylate hydrate
|
US9290445B2
(en)
*
|
2008-10-20 |
2016-03-22 |
Xenoport, Inc. |
Methods of synthesizing a levodopa ester prodrug
|
US20110294860A1
(en)
*
|
2008-12-17 |
2011-12-01 |
Medrx Co., Ltd. |
Aqueous oral preparation of stable amlodipine
|
EA020103B1
(ru)
|
2009-01-23 |
2014-08-29 |
Ханми Сайенс Ко., Лтд. |
Твердая фармацевтическая композиция, содержащая амлодипин и лозартан, и способ ее получения
|
WO2011056240A2
(en)
*
|
2009-11-09 |
2011-05-12 |
Xenoport, Inc. |
Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
|
MX2012006566A
(es)
|
2009-12-09 |
2012-11-29 |
Univ Ramot |
Metodo para mejorar las funciones cognoscitivas.
|
KR20120127495A
(ko)
|
2010-02-12 |
2012-11-21 |
화이자 인코포레이티드 |
8-플루오로-2-{4-[(메틸아미노)메틸]페닐}-1,3,4,5-테트라하이드로-6h-아제피노[5,4,3-cd]인돌-6-온의 염 및 다형체
|
WO2011104637A2
(en)
|
2010-02-24 |
2011-09-01 |
Ramot At Tel-Aviv University Ltd. |
Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same
|
WO2011117876A1
(en)
|
2010-03-26 |
2011-09-29 |
Fdc Limited |
An improved process for the preparation of amlodipine free base and acid addition salts thereof
|
IT1400309B1
(it)
*
|
2010-05-10 |
2013-05-24 |
Menarini Int Operations Lu Sa |
Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
|
EP2425859A1
(en)
|
2010-08-08 |
2012-03-07 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Olmesartan formulations
|
SG187796A1
(en)
*
|
2010-08-10 |
2013-03-28 |
Celgene Avilomics Res Inc |
Besylate salt of a btk inhibitor
|
WO2012038963A1
(en)
|
2010-09-22 |
2012-03-29 |
Ramot At Tel-Aviv University Ltd. |
An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
|
WO2012061303A1
(en)
|
2010-11-01 |
2012-05-10 |
Avila Therapeutics, Inc. |
Heteroaryl compounds and uses thereof
|
JP5957460B2
(ja)
|
2010-11-01 |
2016-07-27 |
セルジーン アヴィロミクス リサーチ, インコーポレイテッド |
複素環式化合物またはその使用
|
WO2012064706A1
(en)
|
2010-11-10 |
2012-05-18 |
Avila Therapeutics, Inc. |
Mutant-selective egfr inhibitors and uses thereof
|
WO2012071524A1
(en)
*
|
2010-11-24 |
2012-05-31 |
Ratiopharm Gmbh |
Arylsulfonate salts of fingolimod and processes for preparation thereof
|
JP2014532658A
(ja)
|
2011-10-28 |
2014-12-08 |
セルジーン アヴィロミクス リサーチ, インコーポレイテッド |
ブルトン型チロシンキナーゼ疾患または障害を治療する方法
|
SI2825042T1
(sl)
|
2012-03-15 |
2019-01-31 |
Celgene Car Llc |
Soli inhibitorja kinaze receptorja faktorja epidermalne rasti
|
RU2673077C2
(ru)
|
2012-03-15 |
2018-11-22 |
Селджен Авиломикс Рисерч, Инк. |
Твёрдые формы ингибитора киназы рецептора эпидермального фактора роста
|
EP2935226A4
(en)
|
2012-12-21 |
2016-11-02 |
Celgene Avilomics Res Inc |
HETEROARYL COMPOUNDS AND USES THEREOF
|
PL236001B1
(pl)
|
2012-12-21 |
2020-11-30 |
Adamed Spolka Z Ograniczona Odpowiedzialnoscia |
Złożona kompozycja farmaceutyczna zawierająca kandesartan cyleksetylu oraz amlodypinę, sposób jej wytwarzania oraz jednostkowa postać dawkowania zawierająca tę kompozycję
|
WO2014122585A1
(en)
|
2013-02-08 |
2014-08-14 |
Wockhardt Limited |
A stable pharmaceutical composition of amlodipine and benazepril or salts thereof
|
ES2805359T3
(es)
|
2013-02-08 |
2021-02-11 |
Celgene Car Llc |
Inhibidores de ERK y sus usos
|
JP2016516804A
(ja)
|
2013-04-17 |
2016-06-09 |
ファイザー・インク |
心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体
|
US9492471B2
(en)
|
2013-08-27 |
2016-11-15 |
Celgene Avilomics Research, Inc. |
Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
|
US9415049B2
(en)
|
2013-12-20 |
2016-08-16 |
Celgene Avilomics Research, Inc. |
Heteroaryl compounds and uses thereof
|
TW201613892A
(en)
|
2014-08-13 |
2016-04-16 |
Celgene Avilomics Res Inc |
Forms and compositions of an ERK inhibitor
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
CN104523588A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-硬脂酸离子液体及其制备方法和用途
|
CN104610130A
(zh)
*
|
2015-01-22 |
2015-05-13 |
华东理工常熟研究院有限公司 |
氨氯地平-棕榈酸离子液体及其制备方法和用途
|
CN104529877A
(zh)
*
|
2015-01-22 |
2015-04-22 |
华东理工常熟研究院有限公司 |
氨氯地平-癸酸离子液体及其制备方法和用途
|
WO2017030893A1
(en)
|
2015-08-14 |
2017-02-23 |
Endocyte, Inc. |
Method of imaging with a chelating compound
|
US20180303811A1
(en)
|
2015-10-23 |
2018-10-25 |
Ftf Pharma Private Limited |
Oral solution of dihydropyridine derivatives
|
CN105395495A
(zh)
*
|
2015-11-30 |
2016-03-16 |
宜昌东阳光长江药业股份有限公司 |
一种含有苯磺酸氨氯地平的组合物及其制备方法
|
EP3219309A1
(en)
|
2016-03-17 |
2017-09-20 |
K.H.S. Pharma Holding GmbH |
Fixed dosed pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension
|
JP6411662B2
(ja)
|
2016-05-30 |
2018-10-24 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
固定容量配合剤
|
EP3522872B1
(en)
|
2016-10-07 |
2021-08-11 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
US10350171B2
(en)
|
2017-07-06 |
2019-07-16 |
Dexcel Ltd. |
Celecoxib and amlodipine formulation and method of making the same
|
EP3501502A1
(en)
|
2017-12-20 |
2019-06-26 |
Midas Pharma GmbH |
Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
|
WO2019200143A1
(en)
|
2018-04-11 |
2019-10-17 |
Silvergate Pharmaceuticals, Inc. |
Amlodipine formulations
|
JP7470647B2
(ja)
|
2018-06-14 |
2024-04-18 |
アストラゼネカ・ユーケイ・リミテッド |
ジヒドロピリジン型カルシウムチャネル遮断薬医薬組成物を用いて血圧を低下させるための方法
|
JOP20210193A1
(ar)
|
2019-01-18 |
2023-01-30 |
Astrazeneca Ab |
مثبطات pcsk9 وطرق استخدامها
|
US11253474B1
(en)
|
2021-02-01 |
2022-02-22 |
Liqmeds Worldwide Limited |
Pharmaceutical solution of amlodipine
|
EP4052695A1
(en)
|
2021-03-05 |
2022-09-07 |
Midas Pharma GmbH |
Stable oral fixed-dose immediate release pharmaceutical compositions comprising amlodipine, atorvastatin and candesartan cilexetil
|
WO2023285646A1
(en)
|
2021-07-15 |
2023-01-19 |
Adamed Pharma S.A |
A pharmaceutical composition comprising amlodipine, candesartan cilexetil and hydrochlorothiazide for the treatment of hypertension
|